- Round ID
- FR-00384
- Stage
- Series B
- Round name
- Series B
- Amount
- $97M
Dated funding evidence
MiroBio
Series B · $97M · 2022-06-01
Reported round$97MSeries B
- Disclosure date
- 2022-06-01
- Reported currency
- USD
- Companies House
- 11609215
- Evidence sources
- 2
Company
MiroBioCH 116092152022-06-01Series B$97M
Resolved investor records
Oxford Science EnterprisesInvestorSamsara BioCapitalInvestorSR OneInvestorMedicxiInvestorAdvent Life SciencesInvestorOrbiMedInvestorMonographInvestor
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- not specified in source
- Other investors
- Oxford Science Enterprises, Samsara BioCapital, SR One, Medicxi, Advent Life Sciences, OrbiMed, Monograph
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-25
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.